Trademark Overview
On Thursday, July 2, 2026, a trademark application was filed for PRELI with the United States Patent and Trademark Office. The USPTO has given the PRELI trademark a serial number of 99918701. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, July 2, 2026. This trademark is owned by Xambika Biotech B.V.. The PRELI trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical products for human use, namely, pharmaceutical preparations for endometrial health purposes; Pharmaceutical products for treating disorders and disturbances of the endometrium; Clinical diagnostic test kits for testing biopsy and other tissue samples for use in detecting disorders of the endometrium consisting primarily of medical diagnostic reagents; Diagnostic agents, for medical use; Diagnostic preparations, for medical purposes; Clinical diagnostic reagents for medical use; Medical diagnostic test strips for blood analysis, urine analysis, saliva analysis and decidual reaction analysis; Diagnostic test kits for medical purposes consisting primarily of medical diagnostic reagents; In vitro diagnostic preparations for medical purposes; Indicators in the nature of protein arrays for medical diagnosis
Laboratory testing of materials; Laboratory services for the production of pharmaceuticals; Research laboratory analysis services in the field of of gynecology, obstetrics, and reproductive endocrinology and infertility (REI); Analytical laboratories, namely, scientific laboratory services; Chemical laboratories; Laboratory research services relating to pharmaceuticals; Scientific laboratory services; Biological research laboratory services
